Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

SYGNIS, GeneWorks ink distribution deal
October 2015
SHARING OPTIONS:

HEIDELBERG, Germany—SYGNIS AG and GeneWorks Pty Ltd. have signed a non-exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia. Per the terms of the agreement, GeneWorks will be granted the rights to promote, market and sell all existing and future products, including SYNGIS’ TruePrime products for primer-free WGA and SunScript thermostable reverse transcriptase kits for the translation of RNA into DNA to scientists working in genomics, proteomics and diagnostics in Australia. No financial details were disclosed.
 
“We are very pleased about the distribution agreement with GeneWorks for the Australian continent, which significantly strengthens our worldwide presence and perfectly positions our products in the rapidly growing biotechnology industry,” Pilar de la Huerta, CEO and chief financial officer of SYGNIS, said in a press release.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.